Bruker/$BRKR
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Bruker
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
Ticker
$BRKR
Sector
Primary listing
Employees
11,085
Headquarters
Website
Bruker Metrics
BasicAdvanced
$5.6B
-
-$0.15
1.19
$0.20
0.55%
Price and volume
Market cap
$5.6B
Beta
1.19
52-week high
$56.22
52-week low
$28.53
Average daily volume
2.4M
Dividend rate
$0.20
Financial strength
Current ratio
1.73
Quick ratio
0.66
Long term debt to equity
73.796
Total debt to equity
81.381
Interest coverage (TTM)
7.88%
Profitability
EBITDA (TTM)
455.2
Gross margin (TTM)
47.95%
Net profit margin (TTM)
-0.25%
Operating margin (TTM)
6.84%
Effective tax rate (TTM)
139.52%
Revenue per employee (TTM)
$310,000
Management effectiveness
Return on assets (TTM)
2.44%
Return on equity (TTM)
-0.38%
Valuation
Price to revenue (TTM)
1.62
Price to book
2.27
Price to tangible book (TTM)
606.59
Price to free cash flow (TTM)
1,465.324
Free cash flow yield (TTM)
0.07%
Free cash flow per share (TTM)
0.025
Dividend yield (TTM)
0.55%
Forward dividend yield
0.55%
Growth
Revenue change (TTM)
2.08%
Earnings per share change (TTM)
-119.76%
3-year revenue growth (CAGR)
10.74%
10-year revenue growth (CAGR)
7.79%
3-year earnings per share growth (CAGR)
-57.76%
10-year earnings per share growth (CAGR)
-12.94%
What the Analysts think about Bruker
Analyst ratings (Buy, Hold, Sell) for Bruker stock.
Bruker Financial Performance
Revenues and expenses
Bruker Earnings Performance
Company profitability
Bruker News
AllArticlesVideos
Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR
Business Wire·2 weeks ago
Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications
Business Wire·2 weeks ago
Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology
Business Wire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Bruker stock?
Bruker (BRKR) has a market cap of $5.6B as of March 08, 2026.
What is the P/E ratio for Bruker stock?
The price to earnings (P/E) ratio for Bruker (BRKR) stock is 0 as of March 08, 2026.
Does Bruker stock pay dividends?
Yes, the Bruker (BRKR) stock pays dividends to shareholders. As of March 08, 2026, the dividend rate is $0.2 and the yield is 0.55%. Bruker has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Bruker dividend payment date?
The next Bruker (BRKR) dividend payment is scheduled for April 07, 2026.
What is the beta indicator for Bruker?
Bruker (BRKR) has a beta rating of 1.19. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.